Clinical Trial Detail

NCT ID NCT02471911
Title KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Dexamethasone

Carboplatin + Etoposide + Ifosfamide + Rituximab

Selinexor

Age Groups: adult

No variant requirements are available.